FDA approves Xenleta for community-acquired bacterial pneumonia treatment
August 20, 2019
The approval was based on results from two trials with a total of 1,289 patients.
Patients with COPD at heightened risk for community-acquired pneumonia requiring hospitalization
July 11, 2019
COPD patients were about 18 times more likely to develop community-acquired pneumonia requiring hospitalization.
Medicare may best Medicare Advantage at reducing readmissions
June 25, 2019
Editorialists provide reasons to exercise caution when interpreting the results.
Most measles cases in 25 years prompts government pleas to vaccinate
April 29, 2019
CDC update coincides with National Infant Immunization Week campaign to reinforce message that vaccines are safe and effective.
Ibrexafungerp effective against C. auris in two early case reports
April 18, 2019
Early findings from the CARES study show clinical improvement and eradication of candidemia.
Prescribed opioids increase pneumonia risk in patients with, without HIV
January 23, 2019
Community-acquired pneumonia risk was greatest with higher doses and immunosuppressive opioids.
Hospital Readmissions Reduction Program may be doing more harm than good
January 4, 2019
Thirty-day postdischarge mortality went up after the program for some, down for others.
Guideline-concordant treatment still unlikely in nonchildren’s hospitals for pediatric CAP
December 19, 2018
This is concerning because the majority of children hospitalized with pneumonia are treated in nonchildren’s hospitals.
ICU-acquired pneumonia mortality risk may be underestimated
December 6, 2018
Hospital-acquired pneumonia imposes a greater mortality toll at 30 days than ventilator-associated pneumonia.
FDA approves omadacycline for pneumonia and skin infections
October 4, 2018
The tetracycline antibiotic was approved for CABP and acute bacterial skin and skin structure infections in adults.